These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 2023219)

  • 21. Stress-relaxation and contraction of a collagen matrix induces expression of TGF-beta and triggers apoptosis in dermal fibroblasts.
    Varedi M; Tredget EE; Ghahary A; Scott PG
    Biochem Cell Biol; 2000; 78(4):427-36. PubMed ID: 11012081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
    Davies CA; Jeziorska M; Freemont AJ; Herrick AL
    Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
    Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High plasminogen activator inhibitor type 2 expression is a hallmark of scleroderma fibroblasts in vitro.
    Kessler-Becker D; Smola S; Krieg T; Eckes B
    Exp Dermatol; 2004 Nov; 13(11):708-14. PubMed ID: 15500643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
    Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
    Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
    Ihn H; Tamaki K
    Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
    Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
    Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor.
    Tan EM; Hoffren J; Rouda S; Greenbaum S; Fox JW; Moore JH; Dodge GR
    Exp Cell Res; 1993 Dec; 209(2):200-7. PubMed ID: 8262136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of transforming growth factor-beta1, fibronectin, and Types I, III, and VI collagen genes in fascial fibroblasts from patients with diffuse fasciitis with eosinophilia.
    Kahari L; Jimenez SA
    J Rheumatol; 1996 Mar; 23(3):482-6. PubMed ID: 8832987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF beta--a role in systemic sclerosis?
    Cotton SA; Herrick AL; Jayson MI; Freemont AJ
    J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.